Trends and patterns of antibiotics use in Serbia from 2006 to 2021: Pre-COVID-19 period versus COVID-19 pandemic - 23/02/24
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Résumé |
Background |
Global rise in antibiotic utilization has been strongly associated with the resistance of bacteria to antibiotics. The COVID-19 saw an increase in the use of antibiotics in some countries. The aim of this study was to evaluate antibiotic utilization from 2006 to 2021 in the Republic of Serbia.
Methods |
Data on antibiotic use were retrieved from the national annual reports on the official website of the Medicines and Medical Devices Agency of Serbia during the period 2006 to 2021. To evaluate trends in the use of antibiotics in Serbia, linear, and joint regression analyses were performed.
Results |
The analysis of the antibiotics use over a sixteen-year period included a total of 50 antibiotics. A significant increase during the COVID-19 pandemic was observed for glycylcyclines that is, new-generation tetracyclines (tigecycline), third-generation cephalosporins (ceftazidime, ceftriaxone, and cefixime), respiratory fluoroquinolones (levofloxacin and moxifloxacin), carbapenems (ertapenem), and oxazolidinones (linezolid) utilization. Moreover, an almost negligible use of new β-lactam/β-lactamase inhibitors during the prepandemic period increased significantly during the COVID-19 pandemic period.
Conclusions |
A significant increasing trend in the use of specific antibiotics classified as the "Watch" and "Reserve" antibiotics during the pandemic period was observed.
Le texte complet de cet article est disponible en PDF.Highlights |
• | From 2006 to 2021 a total of 50 antibiotics for systemic use were continuously used. |
• | In this period, a decrease in antibacterials use was observed. |
• | During COVID-19 pandemic utilization of some antibiotics has increased. |
Key Words : Join-point
Plan
| Conflicts of interest: None to report. |
Vol 52 - N° 3
P. 293-304 - mars 2024 Retour au numéro
Article précédent
- Health care–associated Clostridioides difficile infection: Learning the perspectives of health care workers to build successful strategies
- Vered Lev, Teni Anbarchian, Hanqi Yao, Akanshya Bhat, Patricia Britt, Lisa Shieh
- The impact of the COVID-19 pandemic on gram-negative bacteria susceptibility patterns in respiratory samples of intensive care units in the Brussels Capital Region, 2010-2021
- Marco Moretti, Véronique Y. Miendje Deyi, Deborah De Geyter, Ingrid Wybo, Marc Claus, Joop Jonckheer, Philippe Clevenbergh, Nicolas Dauby
Bienvenue sur EM-consulte, la référence des professionnels de santé.